| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chloride channel regulator activity | 7.64e-05 | 15 | 113 | 3 | GO:0017081 | |
| GeneOntologyBiologicalProcess | regulation of Rho protein signal transduction | 8.83e-07 | 98 | 109 | 7 | GO:0035023 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | CUL3 RDX BCL6 ARHGAP35 RALGAPA2 F2RL1 CSNK1A1L NF1 CSNK1A1 AKAP13 | 1.09e-05 | 333 | 109 | 10 | GO:0051056 |
| GeneOntologyBiologicalProcess | establishment of endothelial barrier | 1.38e-05 | 58 | 109 | 5 | GO:0061028 | |
| GeneOntologyBiologicalProcess | Rho protein signal transduction | 2.67e-05 | 164 | 109 | 7 | GO:0007266 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | CUL3 RDX BCL6 ARHGAP35 RALGAPA2 F2RL1 CSNK1A1L NF1 RAPGEF3 CSNK1A1 AKAP13 RAPGEF2 | 2.76e-05 | 538 | 109 | 12 | GO:0007264 |
| GeneOntologyBiologicalProcess | Rap protein signal transduction | 5.01e-05 | 14 | 109 | 3 | GO:0032486 | |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 6.43e-05 | 41 | 109 | 4 | GO:0035025 | |
| GeneOntologyBiologicalProcess | endothelial cell development | 6.59e-05 | 80 | 109 | 5 | GO:0001885 | |
| GeneOntologyBiologicalProcess | glucocorticoid mediated signaling pathway | 1.65e-04 | 4 | 109 | 2 | GO:0043402 | |
| Domain | SPRY | 2.16e-05 | 94 | 112 | 6 | PF00622 | |
| Domain | SPRY_dom | 2.16e-05 | 94 | 112 | 6 | IPR003877 | |
| Domain | B30.2/SPRY | 2.29e-05 | 95 | 112 | 6 | IPR001870 | |
| Domain | B302_SPRY | 2.29e-05 | 95 | 112 | 6 | PS50188 | |
| Domain | BBOX | 5.87e-05 | 69 | 112 | 5 | SM00336 | |
| Domain | Butyrophylin | 6.29e-05 | 70 | 112 | 5 | IPR003879 | |
| Domain | - | 6.73e-05 | 71 | 112 | 5 | 4.10.45.10 | |
| Domain | ZF_BBOX | 1.19e-04 | 80 | 112 | 5 | PS50119 | |
| Domain | Znf_B-box | 1.26e-04 | 81 | 112 | 5 | IPR000315 | |
| Domain | SPRY | 1.77e-04 | 87 | 112 | 5 | SM00449 | |
| Domain | RII_binding_1 | 3.52e-04 | 5 | 112 | 2 | PF10522 | |
| Domain | RII_binding_1 | 3.52e-04 | 5 | 112 | 2 | IPR018459 | |
| Domain | - | ADCY10 ABCA3 MYO7B CFTR SMC6 MCM7 ZNFX1 HNRNPUL1 ARHGAP35 FANCM SBNO1 GET3 DHX35 | 5.28e-04 | 746 | 112 | 13 | 3.40.50.300 |
| Domain | Ubiquitin-rel_dom | 8.50e-04 | 184 | 112 | 6 | IPR029071 | |
| Domain | zf-B_box | 9.21e-04 | 72 | 112 | 4 | PF00643 | |
| Domain | Helicase/UvrB_N | 9.75e-04 | 8 | 112 | 2 | IPR006935 | |
| Domain | ResIII | 9.75e-04 | 8 | 112 | 2 | PF04851 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HK2 ACACA ERP44 PITRM1 PDHA1 SYNE1 MATR3 SMC6 RDX MCM7 HNRNPUL1 TTC3 DARS2 RRP1 NF1 SBNO1 UTP15 GLUD1 FEN1 AHCY FAR1 SEC63 VCL | 1.74e-10 | 1425 | 113 | 23 | 30948266 |
| Pubmed | Human chromosome 11 DNA sequence and analysis including novel gene identification. | 2.30e-10 | 80 | 113 | 8 | 16554811 | |
| Pubmed | 9.69e-10 | 15 | 113 | 5 | 19703589 | ||
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 3.71e-09 | 19 | 113 | 5 | 22144910 | |
| Pubmed | CUL3 HK2 ACACA ERP44 PDHA1 MATR3 MCM7 BIRC6 DARS2 FEN1 AHCY SNX27 FAR1 | 2.16e-08 | 534 | 113 | 13 | 35032548 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CUL3 CACNA1S HK2 ACACA ERP44 ACADM PDHA1 RDX MCM7 HNRNPUL1 BIRC6 PGGT1B SEC24D SBNO1 GET3 FEN1 AHCY NMT1 VCL RAD23A | 4.58e-08 | 1455 | 113 | 20 | 22863883 |
| Pubmed | CUL3 MATR3 MCM7 RALGAPA2 ADCY2 KCNV1 NF1 SHANK2 RAPGEF3 RAPGEF2 TMCO1 NMT1 | 3.55e-07 | 568 | 113 | 12 | 9110174 | |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | CUL3 MATR3 MCM7 RALGAPA2 ADCY2 KCNV1 NF1 SHANK2 RAPGEF3 RAPGEF2 TMCO1 NMT1 | 3.97e-07 | 574 | 113 | 12 | 8619474 |
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.01e-06 | 55 | 113 | 5 | 19468303 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CUL3 PITRM1 VPS50 SMC6 MCM7 HNRNPUL1 DARS2 PHKG2 NF1 SBNO1 CSNK1A1 GCC2 WDR35 SNX27 NMT1 CAMSAP2 VCL | 1.30e-06 | 1321 | 113 | 17 | 27173435 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HK2 ACADM PITRM1 PDHA1 SYNE1 MATR3 HNRNPUL1 TTC3 BIRC6 DARS2 RRP1 DNAJC28 UTP15 GLUD1 DHX35 ALAS1 SEC63 TMCO1 | 1.59e-06 | 1496 | 113 | 18 | 32877691 |
| Pubmed | 2.17e-06 | 64 | 113 | 5 | 26511642 | ||
| Pubmed | 2.30e-06 | 451 | 113 | 10 | 36168627 | ||
| Pubmed | CUL3 SYNE1 MATR3 RDX ZNFX1 TTC3 AP1S1 CSNK1A1L NF1 SHANK2 CSNK1A1 RAPGEF2 CABIN1 CAMSAP2 | 3.06e-06 | 963 | 113 | 14 | 28671696 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HK2 ACACA ERP44 MATR3 RDX MCM7 HNRNPUL1 ARHGAP35 BIRC6 DARS2 SBNO1 CSNK1A1 GLUD1 FEN1 AHCY AKAP13 NMT1 | 3.28e-06 | 1415 | 113 | 17 | 28515276 |
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 5.27e-06 | 134 | 113 | 6 | 28695742 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ACACA ACADM PDHA1 MATR3 RDX MCM7 HNRNPUL1 DARS2 RRP1 AP1S1 UTP15 GLUD1 FEN1 FAR1 TAF6 SEC63 | 5.77e-06 | 1318 | 113 | 16 | 30463901 |
| Pubmed | HK2 ACACA PITRM1 PDHA1 MATR3 SMC6 ZSWIM6 HNRNPUL1 BIRC6 PGGT1B NF1 SBNO1 UBP1 ECEL1 TAF6 SEC63 | 6.28e-06 | 1327 | 113 | 16 | 32694731 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK2 ACACA PDHA1 MATR3 RIOK3 MCM7 HNRNPUL1 BIRC6 NF1 UTP15 FEN1 AHCY SNX27 AKAP13 FAR1 VCL | 8.00e-06 | 1353 | 113 | 16 | 29467282 |
| Pubmed | 9.06e-06 | 224 | 113 | 7 | 32941674 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20309575 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30575436 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23354688 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19812353 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 25060325 | ||
| Pubmed | Tissue-specific distribution of mouse casein kinase I alpha mRNA. | 1.05e-05 | 2 | 113 | 2 | 9522121 | |
| Pubmed | CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling. | 1.05e-05 | 2 | 113 | 2 | 37723657 | |
| Pubmed | Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice. | 1.05e-05 | 2 | 113 | 2 | 36929849 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 18209474 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 35695793 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26294672 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 14679199 | ||
| Pubmed | Exploring the role of casein kinase 1α splice variants across cancer cell lines. | 1.05e-05 | 2 | 113 | 2 | 38852281 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23690993 | ||
| Pubmed | Potentiation of ABCA3 lipid transport function by ivacaftor and genistein. | 1.05e-05 | 2 | 113 | 2 | 31210424 | |
| Pubmed | Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice. | 1.05e-05 | 2 | 113 | 2 | 36542875 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21047789 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 35260737 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17540036 | ||
| Pubmed | Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism. | 1.05e-05 | 2 | 113 | 2 | 25994086 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20932849 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24811177 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30892081 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 15639479 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 34216174 | ||
| Pubmed | Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling. | 1.05e-05 | 2 | 113 | 2 | 37108197 | |
| Pubmed | TRPV1 and BDKRB2 receptor polymorphisms can influence the exercise pressor reflex. | 1.05e-05 | 2 | 113 | 2 | 30206938 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17595519 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24586903 | ||
| Pubmed | Neuronal expression of soluble adenylyl cyclase in the mammalian brain. | 1.05e-05 | 2 | 113 | 2 | 23611875 | |
| Pubmed | HK2 ERP44 PITRM1 DUSP3 VPS50 BIRC6 DARS2 RRP1 CSNK1A1L AHCY TMCO1 | 1.53e-05 | 686 | 113 | 11 | 28380382 | |
| Pubmed | CUL3 PDHA1 SYNE1 MATR3 RDX ZNFX1 ARHGAP35 CSNK1A1L NF1 SHANK2 CSNK1A1 GLUD1 SNX27 RAPGEF2 CAMSAP2 VCL | 1.60e-05 | 1431 | 113 | 16 | 37142655 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ERP44 PITRM1 DUSP3 MATR3 CSNK1A1L CSNK1A1 DUSP16 GLUD1 SNX27 HOOK2 FAR1 SEC63 VCL | 1.75e-05 | 974 | 113 | 13 | 28675297 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.75e-05 | 344 | 113 | 8 | 30333137 | |
| Pubmed | 2.20e-05 | 17 | 113 | 3 | 12461558 | ||
| Pubmed | 2.20e-05 | 17 | 113 | 3 | 21364888 | ||
| Pubmed | PDE7A PDHA1 SYNE1 HNRNPUL1 TTC3 DARS2 RRP1 DNAJC28 UTP15 GLUD1 AKAP13 ALAS1 FAR1 SEC63 VCL RAD23A | 2.55e-05 | 1487 | 113 | 16 | 33957083 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.57e-05 | 363 | 113 | 8 | 14691545 | |
| Pubmed | Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. | 3.13e-05 | 3 | 113 | 2 | 24616378 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 32238906 | ||
| Pubmed | Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. | 3.13e-05 | 3 | 113 | 2 | 25242043 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 28655862 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 27558159 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 22309306 | ||
| Pubmed | CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation. | 3.13e-05 | 3 | 113 | 2 | 28878021 | |
| Pubmed | A negative feedback loop mediated by the Bcl6-cullin 3 complex limits Tfh cell differentiation. | 3.13e-05 | 3 | 113 | 2 | 24863065 | |
| Pubmed | Type I Interferons Control Proliferation and Function of the Intestinal Epithelium. | 3.13e-05 | 3 | 113 | 2 | 26811327 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19805514 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 35148462 | ||
| Pubmed | 3.71e-05 | 497 | 113 | 9 | 23414517 | ||
| Pubmed | 5.37e-05 | 202 | 113 | 6 | 29540532 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACACA MATR3 RDX HNRNPUL1 ARHGAP35 GLUD1 FEN1 AHCY TAF6 NMT1 CAMSAP2 VCL | 5.41e-05 | 934 | 113 | 12 | 33916271 |
| Pubmed | ACACA PDHA1 MATR3 RDX MCM7 HNRNPUL1 RRP1 CSNK1A1 GET3 GLUD1 AHCY DHX35 CAMSAP2 VCL | 5.43e-05 | 1247 | 113 | 14 | 27684187 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CUL3 HK2 ACACA ERP44 ACADM PDHA1 MATR3 MCM7 HNRNPUL1 BIRC6 GLUD1 AHCY FAR1 TMCO1 | 5.91e-05 | 1257 | 113 | 14 | 37317656 |
| Pubmed | The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. | 6.25e-05 | 4 | 113 | 2 | 32728212 | |
| Pubmed | Regulation of p53-MDMX interaction by casein kinase 1 alpha. | 6.25e-05 | 4 | 113 | 2 | 16024788 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 30487124 | ||
| Pubmed | Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. | 6.25e-05 | 4 | 113 | 2 | 20855527 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 38147624 | ||
| Pubmed | EPAC1 activation by cAMP stabilizes CFTR at the membrane by promoting its interaction with NHERF1. | 6.25e-05 | 4 | 113 | 2 | 27206858 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 23974956 | ||
| Pubmed | FAM83D directs protein kinase CK1α to the mitotic spindle for proper spindle positioning. | 6.25e-05 | 4 | 113 | 2 | 31338967 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 25384981 | ||
| Pubmed | Cx43 phosphorylation sites regulate pancreatic cancer metastasis. | 6.25e-05 | 4 | 113 | 2 | 33603164 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 21763756 | ||
| Pubmed | PDE7A SYNE1 RDX ZNFX1 HNRNPUL1 REV3L TTC3 SBNO1 GLUD1 AHCY DHX35 RAPGEF2 TAF6 CABIN1 | 7.47e-05 | 1285 | 113 | 14 | 35914814 | |
| Pubmed | MAN2A1 ACACA ERP44 DUSP3 RDX HNRNPUL1 BIRC6 DARS2 SEC24D AHCY AKAP13 ECEL1 SEC63 TMCO1 | 8.24e-05 | 1297 | 113 | 14 | 33545068 | |
| Pubmed | 8.28e-05 | 317 | 113 | 7 | 30997501 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | CUL3 ACACA MATR3 RDX MCM7 HNRNPUL1 PHKG2 GET3 GLUD1 FEN1 AHCY NMT1 VCL | 9.44e-05 | 1149 | 113 | 13 | 35446349 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 1.04e-04 | 704 | 113 | 10 | 29955894 | |
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 36989576 | ||
| Pubmed | Rescue of DeltaF508-CFTR by the SGK1/Nedd4-2 signaling pathway. | 1.04e-04 | 5 | 113 | 2 | 19617352 | |
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 29777060 | ||
| Pubmed | CKIα ablation highlights a critical role for p53 in invasiveness control. | 1.04e-04 | 5 | 113 | 2 | 21331045 | |
| Pubmed | Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer. | 1.04e-04 | 5 | 113 | 2 | 25628462 | |
| Pubmed | Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice. | 1.04e-04 | 5 | 113 | 2 | 30064974 | |
| Pubmed | A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. | 1.04e-04 | 5 | 113 | 2 | 23890787 | |
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 37944068 | ||
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 30651631 | ||
| Pubmed | ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer. | 1.04e-04 | 5 | 113 | 2 | 28468577 | |
| Cytoband | 11q14.3 | 1.19e-06 | 32 | 113 | 4 | 11q14.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q14 | 4.44e-05 | 156 | 113 | 5 | chr11q14 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 2.89e-05 | 95 | 68 | 5 | 59 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 1.73e-04 | 29 | 68 | 3 | 754 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 4.93e-04 | 9 | 68 | 2 | 90 | |
| GeneFamily | Ring finger proteins | 5.83e-04 | 275 | 68 | 6 | 58 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 6.15e-04 | 10 | 68 | 2 | 53 | |
| GeneFamily | Olfactory receptors, family 2 | 8.66e-04 | 113 | 68 | 4 | 149 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 5.30e-03 | 29 | 68 | 2 | 396 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.81e-07 | 197 | 112 | 7 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 7.29e-07 | 199 | 112 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.54e-07 | 200 | 112 | 7 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.98e-06 | 183 | 112 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 198 | 112 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-05 | 198 | 112 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.13e-05 | 199 | 112 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.13e-05 | 199 | 112 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-05 | 136 | 112 | 5 | a43b3db1754c619d328a26a2ba6af4756629a723 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.65e-05 | 168 | 112 | 5 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-05 | 179 | 112 | 5 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | BAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 9.44e-05 | 181 | 112 | 5 | f370161afef2ec827a7b194c06abb9ac1a507cbb | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 9.94e-05 | 183 | 112 | 5 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.02e-04 | 184 | 112 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 184 | 112 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.10e-04 | 187 | 112 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-04 | 187 | 112 | 5 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.10e-04 | 187 | 112 | 5 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 188 | 112 | 5 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.13e-04 | 188 | 112 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 190 | 112 | 5 | c0ee404d705b0b4f0c6ded4d070ad85eac4b16db | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-04 | 191 | 112 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.22e-04 | 191 | 112 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-04 | 191 | 112 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.25e-04 | 192 | 112 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.25e-04 | 192 | 112 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 192 | 112 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.28e-04 | 193 | 112 | 5 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 193 | 112 | 5 | 1fdfe08b0c82248545c29b504ac259b093fde29b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 193 | 112 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 193 | 112 | 5 | 5f90e3e526032d82d9dc7e0813fe79ca28dc0719 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 193 | 112 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-04 | 194 | 112 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-04 | 194 | 112 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.34e-04 | 195 | 112 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 196 | 112 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-04 | 196 | 112 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.37e-04 | 196 | 112 | 5 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 197 | 112 | 5 | 3a0e97bfebe82f9687d518baaad7f20d0ffea8a1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-04 | 198 | 112 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-04 | 198 | 112 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-04 | 199 | 112 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-04 | 199 | 112 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_3|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.47e-04 | 199 | 112 | 5 | 79d87e2b0adeff2d33c3b699afe7211fddc4f285 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-04 | 199 | 112 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.47e-04 | 199 | 112 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 1.51e-04 | 200 | 112 | 5 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 4.06e-06 | 192 | 109 | 8 | 4104_DN | |
| Drug | STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A | 4.22e-06 | 193 | 109 | 8 | 6869_DN | |
| Drug | 2'(3')-O-(2,4,6-trinitrophenyl)-ADP | 5.87e-06 | 8 | 109 | 3 | CID000644359 | |
| Disease | Colorectal Carcinoma | ABCA3 ACACA SYNE1 CFTR AKAP3 CSNK1A1L NF1 FEN1 VRTN ZNF471 CAMSAP2 | 4.59e-05 | 702 | 106 | 11 | C0009402 |
| Disease | muscular disease (implicated_via_orthology) | 1.27e-04 | 5 | 106 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | fatty liver disease (implicated_via_orthology) | 1.88e-04 | 31 | 106 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 2.15e-04 | 447 | 106 | 8 | C3714756 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 2.65e-04 | 7 | 106 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 8.24e-04 | 12 | 106 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | gastric ulcer (implicated_via_orthology) | 1.13e-03 | 14 | 106 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | femoral neck bone geometry | 1.13e-03 | 14 | 106 | 2 | EFO_0004511 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.53e-03 | 63 | 106 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | Mental Retardation, Psychosocial | 1.62e-03 | 139 | 106 | 4 | C0025363 | |
| Disease | Profound Mental Retardation | 1.62e-03 | 139 | 106 | 4 | C0020796 | |
| Disease | Mental deficiency | 1.62e-03 | 139 | 106 | 4 | C0917816 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 3.08e-03 | 23 | 106 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 3.08e-03 | 23 | 106 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 3.08e-03 | 23 | 106 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 3.08e-03 | 23 | 106 | 2 | C0014556 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLALVKTMSMGRMRG | 156 | P30411 | |
| GRMMMKYRDQRAGKI | 241 | P13569 | |
| ARVAAMKRSGRMNYM | 3461 | Q9NR09 | |
| QSYEALRVMGKMMRE | 461 | P36896 | |
| RTLKIMSGVYSQGMM | 2011 | Q12802 | |
| MMRFMLLFSRQGKLR | 1 | P61966 | |
| KERRLKEYMRMMGLS | 286 | Q99758 | |
| MGIPLYRIKDIRMMY | 466 | Q13085 | |
| MAMKVELARMSYQRA | 326 | P11310 | |
| VIGQKVNLAARMMMY | 406 | Q96PN6 | |
| RMRREKYLIQEMMYE | 916 | Q32M45 | |
| YPIRMSKRMCVLMIT | 131 | Q8NG85 | |
| MLTEIMSMGYERERV | 166 | P54725 | |
| GMLREDSMMEYLKIA | 181 | P35241 | |
| MVLVERKYMGQMCGL | 161 | Q6W4X9 | |
| IYLRMTGRSPRMMKT | 366 | Q8WVX9 | |
| YILMRMKSQAFIEME | 526 | P43243 | |
| MHFILRKYKMREPIM | 116 | P43366 | |
| MMILGLIYMRGNSAR | 171 | Q9HAY2 | |
| RNMTMQRTMKLYRLP | 316 | P30419 | |
| LLRFDQTGLMKQMMT | 766 | Q16706 | |
| RNVKLMRQMLMDAGL | 506 | P13196 | |
| RRYVDKARMVMQTME | 601 | Q96ED9 | |
| MRAIYMKSLRSPMMN | 1561 | Q8IYD8 | |
| YKTRRAVMLKEMMEQ | 1641 | Q8IYD8 | |
| MISGMYMGELVRLIL | 296 | P52789 | |
| VYARSIMEMLRLKGR | 471 | Q6PIU1 | |
| YPIRMSKRMYVLMIT | 131 | Q8NG80 | |
| QYPVLMRRQVCLLMM | 131 | Q8NG97 | |
| EMMLLVAMAIDRYVA | 111 | Q8NH42 | |
| MMKLRRFLVMIQEDY | 191 | Q13946 | |
| TGNMARVMVRYMKYL | 241 | Q969I3 | |
| VKMLPYFGIIRNRMM | 26 | Q9NX36 | |
| MLTERKILGYMQLRK | 21 | P03886 | |
| RRFTMKTVLMLADQM | 106 | Q8N752 | |
| LIIFRRMIMELTMNK | 546 | Q2PPJ7 | |
| RRQILMLRMIMEGQY | 236 | P15735 | |
| RAAARAKLQYMMVMV | 496 | O95672 | |
| FEPLDMKLMRRYIAM | 551 | P33993 | |
| RYAVLMNKKVGLMMA | 131 | Q8NHA4 | |
| AYVLMIRMLRSSAMD | 261 | P55085 | |
| RVNYELKMLIMMVAL | 756 | Q08462 | |
| GMFYRTIRMMENGIK | 66 | P39748 | |
| NGGILELMMRYLKAM | 481 | Q9Y6J0 | |
| YEQRVEAMARMAAMK | 221 | Q8NA47 | |
| TTEMLMKMYGLGLRQ | 476 | Q13698 | |
| IMRTAMKYNLGLDLR | 521 | P00367 | |
| MLVREMMVDPLLTKY | 156 | Q9H5Z1 | |
| MRIRAFPMTMDEKYV | 16 | Q13618 | |
| SATIAIAYIMKRMDM | 251 | Q9BY84 | |
| TLMNMEIADYERLMK | 1156 | Q8IWJ2 | |
| QKMEVMMYGLYRLRA | 281 | P0DN25 | |
| SRMLMPQDIMAYRGR | 146 | P41182 | |
| GMMMKREYRGQRSVK | 116 | Q9BS26 | |
| SPTLVIAYLMMRQKM | 131 | P51452 | |
| MSYAEVMRLVKGMNF | 146 | O43681 | |
| YRMAVMAMVIKDDRL | 51 | Q7Z4H3 | |
| ENEMPGLMRMRERYS | 26 | P23526 | |
| VAMDMKLRGMYIARQ | 521 | A3KN83 | |
| YMRRKQLKLMEDMDT | 1236 | Q08AD1 | |
| NAIMDKMRVMGLRRQ | 456 | Q9BUJ2 | |
| MDMKKAITYIRRSMS | 191 | P53609 | |
| YLMRMVKALMDNPTL | 281 | P49848 | |
| YQRELLETLGMMDML | 476 | Q8TED0 | |
| MLVYRKMEDVIARMQ | 21 | P49802 | |
| NLRLRSQMVMKMREY | 186 | Q6PI48 | |
| KAKMAHRMEILRGMY | 216 | P0CI25 | |
| NRDLSMVRMKSMFAI | 131 | Q9UM00 | |
| RLYAARKMTRERMMG | 436 | Q17RD7 | |
| RKMTRERMMGEKLFY | 441 | Q17RD7 | |
| MYDELMMIIGSRRSG | 6566 | Q8NF91 | |
| GMVLMRKQVPSRFMY | 51 | Q5T9Z0 | |
| FGMYMERMDKRALIS | 301 | Q9H3E2 | |
| TESRERKYMRSMMIG | 1416 | Q9NTG1 | |
| RKYMRSMMIGIESVL | 1421 | Q9NTG1 | |
| RRFTMKTVLMLADQM | 106 | P48729 | |
| RMRGMVAILIAFMKQ | 16 | O00141 | |
| SGMDQVRLMKRIAEM | 741 | Q5JRX3 | |
| DRLRLDKFYMLMRMV | 111 | P56182 | |
| MMMARKQDVRIPTYN | 1 | Q9NRY4 | |
| LYSEMLMGVMKRRDQ | 276 | Q9UNH6 | |
| RMIMGIIQQKRPYSM | 971 | O94855 | |
| VATMMREKGMYFRRE | 941 | Q9UPX8 | |
| VRSMYLMIKAFLPKM | 106 | Q9BUT1 | |
| TDIMDAMLRKLYNVM | 371 | O75969 | |
| KTRLLMYKMVNSGML | 236 | O14730 | |
| MGRMERRTMIEPDQY | 1186 | Q9Y4G8 | |
| TLNVIRLVGKYMQMM | 611 | Q96JG6 | |
| RLVGKYMQMMNILKP | 616 | Q96JG6 | |
| LINFEKMRMMARAAR | 836 | O95398 | |
| MEYSMVGRTVLDMLI | 446 | Q86UC2 | |
| QTRMAKMGILLREMY | 216 | I1YAP6 | |
| KLSPLMMYEKLSMIR | 226 | Q96HI0 | |
| LNSMFAKVREMLRMR | 361 | Q9P217 | |
| QRIMFDIRLMKEGRM | 451 | Q96LT9 | |
| GLKYYRMMQTVRRME | 61 | P08559 | |
| YRVESMMLRIAKPMN | 2561 | O60673 | |
| QMGIYAVMIEKMILR | 561 | Q8NER1 | |
| KMMSTRRDLYLLMLT | 236 | O75038 | |
| KAKMAHRMEILRGMY | 216 | P0CI26 | |
| AKRMALLMAEMSRLV | 991 | P18206 | |
| MRIVRALGDMVSKYR | 941 | Q9C0B7 | |
| IMKMLRSLIQDGYMA | 486 | P53804 | |
| MMLNLVRYVRVLGNM | 991 | P21359 | |
| YKTRNMDMKRLIMVL | 236 | Q9UGP8 | |
| MDMVNRRIAMDLILK | 1021 | Q96SB8 | |
| IRSMERVMYVMLIIQ | 286 | Q9GZW5 | |
| YEQRKMVMYLNMLRT | 406 | Q96L92 | |
| LRRAYMSIMTQMKES | 711 | Q9P2E3 | |
| SYEIRMLDNRKMGDM | 91 | Q9NZI7 | |
| REMLKMRDSNGARML | 396 | Q9HCJ5 | |
| MNPAQKRLYRSMMLE | 31 | Q9BX82 | |
| DMSMENKPLYQMRLL | 151 | Q9ULT0 | |
| VRMTQHLERMKDMYR | 216 | A6NGJ6 | |
| RDGRMLVMDMIATTK | 636 | Q9H8Y1 | |
| MMEKTRMYVFRNLDP | 611 | Q9P2L0 | |
| VRMTQHLERMKDMYR | 216 | A6NI03 | |
| AMRMQLQGKLRQMTL | 711 | Q6PIF6 |